SEARCH RESULTS FOR: "Tag: BIIB"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2021(2)
2020(5)
2019(16)
2018(11)
2017(19)
2016(20)
2015(23)
2014(3)
CATEGORIES
5-Minute Market Rundown(3)
Analyst Downgrades(4)
Analyst Update(16)
Analyst Upgrades(5)
Buzz Stocks(28)
By the Numbers(4)
Earnings Preview(3)
Expectational Analysis(2)
Ezines(2)
General(14)
Intraday Option Activity(14)
Market Recap(1)
Midday Market Check(5)
Opening View(7)
Quantitative Analysis(2)
Stock Market News(5)
Stocks On the Move(12)
Technical Analysis(1)

4/22/2021 9:57 AM
The shares of Biogen Inc (NASDAQ:BIIB) were last seen down 3.9% at $259.23, even after the pharmaceutical concern posted first-quarter earnings of $5.34 per share, which topped analysts' estimates. T...
1/29/2021 10:24 AM
Biopharmaceutical concern Biogen Inc (NASDAQ:BIIB) is up 7.9% to trade at $291.00 this morning, after the Food and Drug Administration (FDA) extended the review period for Biogen's experimental Alzhe...
12/1/2020 11:57 AM
The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 1.8% at $72.78 at last check, after Raymond James downgraded the stock to "Market Perform" from "Outperform," following its recent $1.5 bill...
7/27/2020 10:36 AM
Pharmaceutical name Biogen Inc (NASDAQ:BIIB) is soaring today, up 4.2% to trade at $283.89, on a double upgrade from Morgan Stanley. The analyst lifted its rating to "overweight" from "underweight" a...
7/22/2020 10:06 AM
The shares of Biogen Inc (NASDAQ: BIIB) are up 1.8% at $285.23 this morning, after the multinational biotechnology company reported second-quarter profits of $10.26 per share on 3.68 billion in revenu...
 
Special Offers from Schaeffer's Trading Partners